The Anti-VEGF Antibody Bevacizumab Potently Reduces the Growth Rate of High-Risk Neuroblastoma Xenografts
Lova Segerström(Karolinska Institutet), Faranak Azarbayjani(Uppsala University)
Cited by 96
Related Papers
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth <i>in vitro</i> and <i>in vivo</i>
|International Journal of Cancer|2011|60
Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments
|Journal of Translational Medicine|2009|8